Who
David W. Meline
Director
Company insider
Files Form 4 as: Director, Hp; Director, Pacific Biosciences of California; Chief Financial Officer, Moderna; EVP & CFO, Amgen; Director, Zf Trw Automotive Holdings; Former Sr. VP & CFO, 3m.
In numbers
- Trades disclosed
- 122
- Buys
- 1
- Sells
- 7
- Bought
- $176K
- Sold
- $4.2M
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 9 Feb 2009
- Last trade
- 16 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Apr 2026filed 20 Apr 2026 | HPQ Hpoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code A | —12,176 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | HPQ Hpoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code A | —12,176 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | HPQ Hpoption or derivative · Hardware, Devices & Storage | SEC FORM 4 Code A | —9,568 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —24,134 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code A | —17,116 at $0.00 | filing |
| 22 Apr 2024filed 24 Apr 2024 | HPQ HpHardware, Devices & Storage | SEC FORM 4 Code A | —7,943 at $0.00 | filing |
| 6 Mar 2024filed 6 Mar 2024 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Bought | $176K40,000 at $4.40 | filing |
| 1 Nov 2023filed 3 Nov 2023 | HPQ HpHardware, Devices & Storage | SEC FORM 4 Code A | —2,747 at $0.00 | filing |
| 13 Oct 2023filed 16 Oct 2023 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —86,954 at $0.00 | filing |
| 10 Aug 2022filed 11 Aug 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $28K164 at $173.66 | filing |
| 9 Aug 2022filed 11 Aug 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —348 at $0.00 | filing |
| 9 Aug 2022filed 11 Aug 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —348 at $0.00 | filing |
| 10 May 2022filed 11 May 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $21K156 at $133.71 | filing |
| 9 May 2022filed 11 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —348 at $0.00 | filing |
| 9 May 2022filed 11 May 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | $47K348 at $134.40 | filing |
| 1 Mar 2022filed 3 Mar 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,020 at $0.00 | filing |
| 1 Mar 2022filed 3 Mar 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,415 at $0.00 | filing |
| 10 Feb 2022filed 11 Feb 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $98K619 at $158.89 | filing |
| 9 Feb 2022filed 11 Feb 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,392 at $0.00 | filing |
| 9 Feb 2022filed 11 Feb 2022 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —1,392 at $0.00 | filing |
News
Moderna (NASDAQ:MRNA) Shares Up 1.2% – Here's WhyMRNA · dailypolitical.com · 13 Oct 2026Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?AMGN · insidermonkey.com · 13 Oct 2026Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?MRNA · insidermonkey.com · 9 Oct 2026Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer's Eye for Different ReasonsAMGN · insidermonkey.com · 8 Oct 20261,272 Amgen Inc. $AMGN Shares Purchased by Venture Visionary Partners LLCAMGN · dailypolitical.com · 8 Oct 2026Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?MRNA · insidermonkey.com · 5 Oct 2026
0 headlines in the last 90 days name David W. Meline; 6 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.